The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma

Ngā tūemi rite

• The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma
  mā: Léon Raymakers, me ētahi atu.
  I whakaputaina: (2025-04-01)
• Rare Case of an Epithelial Cyst in an Intrapancreatic Accessory Spleen Treated by Robot-Assisted Spleen Preserving Distal Pancreatectomy
  mā: Willemijn P. M. van Dijck, me ētahi atu.
  I whakaputaina: (2016-01-01)
• Response to: Comment on “Risk Models for Developing Pancreatic Fistula After Pancreatoduodenectomy: Validation in a Nationwide Prospective Cohort”
  mā: Thijs J. Schouten, MD, me ētahi atu.
  I whakaputaina: (2024-06-01)
• Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design
  mā: L. A. Daamen, me ētahi atu.
  I whakaputaina: (2024-07-01)
• Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design
  mā: L. A. Daamen, me ētahi atu.
  I whakaputaina: (2024-06-01)